Analytical Data
-
基因名
AC1
- Application
-
别名
AC1；AACT；Alpha-1-antichymotrypsin
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P14982
-
表达区间
1-358aa
-
氨基酸序列
MRTPRFRIQAKNVFLTYPKCSIPKEHLLSFIQTLSLQSNPKFIKICRELHQNGEPHLHALIQFEGKITITNNRLFDCVHPSCSTSFHPNIQGAKSSSDVKSYLDKDGDTVEWGQFQIDGRSARGGQQSANDAYAKALNSGSKSEALNVIRELVPKDFVLQFHNLNSNLDRIFQEPPAPYVSPFPCSSFDQVPVEIEEWVADNVRDSAARPWRPNSIVIEGDSRTGKTIWARSLGPHNYLCGHLDLSPKVFNNAAWYNVIDDVDPHYLKHFKEFMGSQRDWQSNTKYGKPVQIKGGIPTIFLCNPGPTSSYKEFLAEEKQEALKAWALKNAIFITLTEPLYSGSNQSHSQTSQEASHPA
-
分子量
42.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AC1 recombinant protein research is centered on understanding the role of AC1, which is an adenylate cyclase implicated in various physiological processes, including signal transduction and cellular communication. Found predominantly in certain pathogens, AC1 is known to modulate host immune responses, which makes it a critical target for both therapeutic and vaccine development. The study of AC1 recombinant proteins allows researchers to dissect its structure-function relationships and create specific inhibitors or immune responses against it. Additionally, the use of recombinant DNA technology facilitates the production of AC1 in heterologous systems, which provides ample quantities for biochemical and biophysical studies. As researchers investigate the potential of AC1 through structural analysis and functional assays, they aim to clarify its mechanisms of action, revealing how it influences host-pathogen interactions. This knowledge could lead to novel strategies for combating infectious diseases, enhancing vaccine efficacy, and elucidating the underlying molecular pathways involved in diseases associated with dysregulated AC1 activity. Overall, the exploration of AC1 recombinant proteins stands at the intersection of molecular biology and immunology, promising significant advances in our understanding of pathogen biology and the development of innovative therapeutic approaches.
